Vaccines Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

Mar 2018| TMR308A| Transparency

Report Highlights

Vaccines Market: Overview

Vaccines help in stimulating the body’s immune system in order to produce antibodies which aid in protecting the body against infectious diseases. The administration of vaccines builds immunity in the body against the disease without contacting the disease. This report analyzes the current and future prospects of the vaccines market based on vaccine type, valance, route of administration, indication, distribution channel and geography.  

Vaccines Market: Research Methodology

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of vaccines in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for vaccine type, valance, route of administration, indication, distribution channel and geography for the period 2016 to 2025.

Vaccines Market: Overview

Vaccines help in stimulating the body’s immune system in order to produce antibodies which aid in protecting the body against infectious diseases. The administration of vaccines builds immunity in the body against the disease without contacting the disease. This report analyzes the current and future prospects of the vaccines market based on vaccine type, valance, route of administration, indication, distribution channel and geography.  

Vaccines Market: Research Methodology

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of vaccines in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for vaccine type, valance, route of administration, indication, distribution channel and geography for the period 2016 to 2025.

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on vaccine type, valance, route of administration, indication, distribution channel and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the vaccines market in the current and future scenario. The report also provides Porter’s five force analysis that studies five factors and their impact on the vaccines market.

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The study also covers detailed country analysis in the respective regions for the vaccines market.

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the vaccines market include GlaxoSmithKline plc. , Sanofi Pasteur SA, Pfizer, Inc., Merck & Co., Inc., Serum Institute of India Ltd, Emergent BioSolutions Inc., CSL Ltd, Janssen Pharmaceutical Company, Novavax AB and Mitsubishi Tanabe Pharma Corporation. New product development was the primary strategy adopted by the major market players to cement their position in the vaccines market.

The vaccines market has been segmented as follows:

Vaccines Market, by Vaccine Type, Revenue (US$ Mn) 2017-2025

Inactivated
Live Attenuated
Toxoid
Conjugate
Others

Vaccines Market, by Valance, Revenue (US$ Mn) 2017-2025

Monovalent
Multivalent

Vaccines Market, by Route of Administration, Revenue (US$ Mn) 2017-2025

Oral
Injectable
Intramuscular
Subcutaneous
Others

Vaccines Market, by Indication, Revenue (US$ Mn) 2017-2025

Influenza
Hepatitis
Polio
Meningococcal Disease
Pneumococcal Disease
DTP
Rotavirus
MMR
Human Papilloma Virus
Others

Vaccines Market, by Distribution Channel, Revenue (US$ Mn) 2017-2025

Institutional Sales
Hospital Pharmacies
Retail Pharmacies

Vaccines Market, by Geography, Revenue (US$ Mn), 2017-2025

North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
India
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC countries
Rest of MEA

  • Table 1 : Global Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
  • Table 2 : Global Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
  • Table 3 : Global Vaccines Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
  • Table 4 : Global Vaccines Market Size (US$ Mn) Forecast, by Route of Administration - InjecTable, 2015–2025
  • Table 5 : Global Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
  • Table 6 : Global Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 7 : Global Vaccines Market (US$ Mn) Forecast, by Region, 2015–2025
  • Table 8 : North America Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 9 : North America Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
  • Table 10 : North America Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
  • Table 11 : North America Vaccines Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
  • Table 12 : North America Vaccines Market Size (US$ Mn) Forecast, by InjecTable, 2015–2025
  • Table 13 : North America Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
  • Table 14 : North America Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 15 : Europe Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 16 : Europe Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
  • Table 17 : Europe Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
  • Table 18 : Europe Vaccines Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
  • Table 19 : Europe Vaccines Market Size (US$ Mn) Forecast, by InjecTable, 2015–2025
  • Table 20 : Europe Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
  • Table 21 : Europe Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 22 : Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 23 : Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
  • Table 24 : Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
  • Table 25 : Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
  • Table 26 : Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by InjecTable, 2015–2025
  • Table 27 : Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
  • Table 28 : Asia Pacific Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 29 : Latin America Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 30 : Latin America Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
  • Table 31 : Latin America Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
  • Table 32 : Latin America Vaccines Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
  • Table 33 : Latin America Vaccines Market Size (US$ Mn) Forecast, by InjecTable, 2015–2025
  • Table 34 : Latin America Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
  • Table 35 : Latin America Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 36 : Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 37 : Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2015–2025
  • Table 38 : Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Valance, 2015–2025
  • Table 39 : Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
  • Table 40 : Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Route of Administration - Injectable, 2015–2025
  • Table 41 : Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Indication, 2015–2025
  • Table 42 : Middle East & Africa Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Figure 1 : Vaccines Market Size (US$ Mn), by Vaccine Type, 2016 (A)
  • Figure 2 : Vaccines Market Revenue (%), by Distribution Channel, 2016 (A)
  • Figure 3 : Global Vaccines Market Revenue (%), by Region, 2016 (A)
  • Figure 4 : Vaccine Type Opportunity Map, 2016
  • Figure 5 : By Valance Opportunity Map, 2016
  • Figure 6 : By Route of Administration Opportunity Map, 2016
  • Figure 7 : By Indication Opportunity Map, 2016
  • Figure 8 : By Distribution Channel Opportunity Map, 2016
  • Figure 9 : Global Vaccines Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 10 : Market Value Share, by Vaccine Type (2016)
  • Figure 11 : Market Value Share, by Valance (2016)
  • Figure 12 : Market Value Share, by Route of Administration (2016)
  • Figure 13 : Market Value Share, by Distribution Channel (2016)
  • Figure 14 : Market Value Share, by Indication (2016)
  • Figure 15 : Market Value Share, by Region (2016)
  • Figure 16 : Global Vaccines Market Value Share, by Vaccine Type, 2016 and 2025
  • Figure 17 : Global Vaccines Market Attractiveness, by Vaccine Type, 2017–2025
  • Figure 18 : Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Inactivated Vaccines, 2015–2025
  • Figure 19 : Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Live Attenuated Vaccines, 2015–2025
  • Figure 20 : Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Toxoid Vaccine, 2015–2025
  • Figure 21 : Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Subunit & Conjugate Vaccine, 2015–2025
  • Figure 22 : Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Vaccines, 2015–2025
  • Figure 23 : Global Vaccines Market Value Share, by Valance, 2016 and 2025
  • Figure 24 : Global Vaccines Market Attractiveness, by Valance, 2017–2025
  • Figure 25 : Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Monovalent Vaccines, 2015–2025
  • Figure 26 : Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Multivalent Vaccines, 2015–2025
  • Figure 27 : Global Vaccines Market Value Share, by Route of Administration, 2016 and 2025
  • Figure 28 : Global Vaccines Market Attractiveness, by Route of Administration, 2017–2025
  • Figure 29 : Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral, 2015–2025
  • Figure 30 : Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by InjecTable, 2015–2025
  • Figure 31 : Global Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
  • Figure 32 : Global Vaccines Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 33 : Global Influenza Market Revenue, US$ Mn, 2017–2025
  • Figure 34 : Global Hepatitis Market Revenue, US$ Mn, 2017–2025
  • Figure 35 : Global Polio Market Revenue, US$ Mn, 2017–2025
  • Figure 36 : Global Meningococcal Disease Market Revenue, US$ Mn, 2017–2025
  • Figure 37 : Global Pneumococcal Disease Market Revenue, US$ Mn, 2017–2025
  • Figure 38 : Global DTP Market Revenue, US$ Mn, 2017–2025
  • Figure 39 : Global Rotavirus Market Revenue, US$ Mn, 2017–2025
  • Figure 40 : Global MMR Market Revenue, US$ Mn, 2017–2025
  • Figure 41 : Global Human Papillomavirus Market Revenue, US$ Mn, 2017–2025
  • Figure 42 : Global Others Disease Market Revenue, US$ Mn, 2017–2025
  • Figure 43 : Global Vaccines Market Attractiveness Analysis, by Indication
  • Figure 44 : Global Vaccines Market Value Share Analysis, by Distribution Channel, 2016 and 2025
  • Figure 45 : Global Institutional Sales Market Revenue, US$ Mn, 2017–2025
  • Figure 46 : Global Hospital Pharmacies Market Revenue, US$ Mn, 2017–2025
  • Figure 47 : Global Retail Pharmacies Market Revenue, US$ Mn, 2017–2025
  • Figure 48 : Global Vaccines Market Attractiveness Analysis, by Distribution Channel
  • Figure 49 : Global Vaccines Market Analysis by Region, 2016 and 2025
  • Figure 50 : Global Vaccines Market Attractiveness Analysis, by Region
  • Figure 51 : North America Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
  • Figure 52 : North America Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
  • Figure 53 : North America Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 54 : North America Vaccines Market Value Share, by Vaccine Type, 2016 and 2025
  • Figure 55 : North America Vaccines Market Attractiveness, by Vaccine Type, 2017–2025
  • Figure 56 : North America Vaccines Market Value Share, by Valance, 2016 and 2025
  • Figure 57 : North America Vaccines Market Attractiveness, by Valance, 2017–2025
  • Figure 58 : North America Vaccines Market Value Share, by Route of Administration, 2016 and 2025
  • Figure 59 : North America Vaccines Market Attractiveness, by Route of Administration, 2017–2025
  • Figure 60 : North America Vaccines Market Value Share, by Indication, 2016 and 2025
  • Figure 61 : North America Vaccines Market Attractiveness, by Indication, 2017–2025
  • Figure 62 : North America Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 63 : North America Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 64 : Europe Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
  • Figure 65 : Europe Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
  • Figure 66 : Europe Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 67 : Europe Vaccines Market Value Share, by Vaccine Type, 2016 and 2025
  • Figure 68 : Europe Vaccines Market Attractiveness, by Vaccine Type, 2017–2025
  • Figure 69 : Europe Vaccines Market Value Share, by Valance, 2016 and 2025
  • Figure 70 : Europe Vaccines Market Attractiveness, by Valance, 2017–2025
  • Figure 71 : Europe Vaccines Market Value Share, by Route of Administration, 2016 and 2025
  • Figure 72 : Europe Vaccines Market Attractiveness, by Route of Administration, 2017–2025
  • Figure 73 : Europe Vaccines Market Value Share, by Indication, 2016 and 2025
  • Figure 74 : Europe Vaccines Market Attractiveness, by Indication, 2017–2025
  • Figure 75 : Europe Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 76 : Europe Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 77 : Asia Pacific Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
  • Figure 78 : Asia Pacific Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
  • Figure 79 : Asia Pacific Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 80 : Asia Pacific Vaccines Market Value Share, by Vaccine Type, 2016 and 2025
  • Figure 81 : Asia Pacific Vaccines Market Attractiveness, by Vaccine Type, 2017–2025
  • Figure 82 : Asia Pacific Vaccines Market Value Share, by Valance, 2016 and 2025
  • Figure 83 : Asia Pacific Vaccines Market Attractiveness, by Valance, 2017–2025
  • Figure 84 : Asia Pacific Vaccines Market Value Share, by Route of Administration, 2016 and 2025
  • Figure 85 : Asia Pacific Vaccines Market Attractiveness, by Route of Administration, 2017–2025
  • Figure 86 : Asia Pacific Vaccines Market Value Share, by Indication, 2016 and 2025
  • Figure 87 : Asia Pacific Vaccines Market Attractiveness, by Indication, 2017–2025
  • Figure 88 : Asia Pacific Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 89 : Asia Pacific Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 90 : Latin America Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
  • Figure 91 : Latin America Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
  • Figure 92 : Latin America Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 93 : Latin America Vaccines Market Value Share, by Vaccine Type, 2016 and 2025
  • Figure 94 : Latin America Vaccines Market Attractiveness, by Vaccine Type, 2017–2025
  • Figure 95 : Latin America Vaccines Market Value Share, by Valance, 2016 and 2025
  • Figure 96 : Latin America Vaccines Market Attractiveness, by Valance, 2017–2025
  • Figure 97 : Latin America Vaccines Market Value Share, by Route of Administration, 2016 and 2025
  • Figure 98 : Latin America Vaccines Market Attractiveness, by Route of Administration, 2017–2025
  • Figure 99 : Latin America Vaccines Market Value Share, by Indication, 2016 and 2025
  • Figure 100 : Latin America Vaccines Market Attractiveness, by Indication, 2017–2025
  • Figure 101 : Latin America Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 102 : Latin America Vaccines Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 103 : Middle East & Africa Vaccines Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2025
  • Figure 104 : Middle East & Africa Vaccines Market Value Share, by Country/Sub-region, 2016 and 2025
  • Figure 105 : Middle East & Africa Vaccines Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 106 : Middle East & Africa Vaccines Market Value Share, by Vaccine Type, 2016 and 2025
  • Figure 107 : Middle East & Africa Vaccines Market Attractiveness, by Vaccine Type, 2017–2025
  • Figure 108 : Middle East & Africa Vaccines Market Value Share, by Valance, 2016 and 2025
  • Figure 109 : Middle East & Africa Vaccines Market Attractiveness, by Valance, 2017–2025
  • Figure 110 : Middle East & Africa Vaccines Market Value Share, by Route of Administration, 2016 and 2025
  • Figure 111 : Middle East & Africa Vaccines Market Attractiveness, by Route of Administration, 2017–2025
  • Figure 112 : Middle East & Africa Vaccines Market Value Share, by Indication, 2016 and 2025
  • Figure 113 : Middle East & Africa Vaccines Market Attractiveness, by Indication, 2017–2025
  • Figure 114 : Middle East & Africa Vaccines Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 115 : Middle East & Africa Vaccines Market Attractiveness, by Distribution Channel, 2017-2025
  • Figure 116 : Global Vaccines Market Share Analysis, by Company (2016)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS